Yes, HPV, Menveo, and Bexsero can be administered simultaneously at different anatomic sites.
Based on FDA labeling and ACIP guidelines, these three vaccines can be given concomitantly during the same visit, but each must be administered at a different anatomic site 1.
Evidence Supporting Concomitant Administration
Menveo with HPV Vaccine
The FDA label for Menveo explicitly addresses this combination. In adolescent clinical trials, Menveo was administered concomitantly with both Tdap and HPV vaccines without interference in meningococcal immune responses 1. While there was a minor reduction in antibody concentrations to certain pertussis antigens (filamentous hemagglutinin and pertactin) when all three were given together compared to Tdap alone, this did not affect the meningococcal vaccine response and is not considered clinically significant.
Bexsero with Other Vaccines
ACIP guidelines state that MenB vaccines (including Bexsero) can be administered simultaneously with other vaccines indicated for the age group, provided they are given at different anatomic sites if feasible 2. Recent research confirms that Bexsero co-administered with MenACWY vaccines (like Menveo) in adolescents aged 16-18 years was well tolerated with comparable immune responses to when vaccines were given separately 3.
HPV Vaccine Coadministration
Systematic reviews demonstrate that HPV vaccines maintain noninferiority of immune response and acceptable safety profiles when coadministered with meningococcal conjugate vaccines 4.
Practical Administration Guidelines
Key requirements:
- Administer each vaccine at a different anatomic site (e.g., one in each deltoid, one in thigh if needed)
- Do not mix any of these vaccines in the same syringe 1
- Use separate syringes and needles for each vaccine
- Document the anatomic site of each vaccine administration
Safety Considerations
Expected reactions:
- Injection site pain is common with all three vaccines
- Bexsero may cause more local reactogenicity than Menveo
- Fever is possible, particularly with Bexsero
- These reactions are generally mild and self-limited
Important caveat: While reactogenicity may be slightly higher when vaccines are given concomitantly compared to separately, no definitive safety concerns have been identified 5. The benefit of completing vaccination in fewer visits typically outweighs the minor increase in transient local reactions.
Clinical Bottom Line
There is no medical reason to separate these vaccines into different visits. Concomitant administration maximizes vaccination opportunities, improves compliance, and is explicitly supported by both FDA labeling and ACIP recommendations 2, 1.